Scholarlink

<p>To demonstrate glutamine (Gln) promotes acute wound healing by mediating Gln metabolism and macrophage M2 polarization through the Mitogen-Activated Protein Kinase Kinase (MEK)/Extracellular Regulated Protein Kinases (ERK)/Solute Carrier Family 1 Member 5 (SLC1A5) signaling axis.Thirty C57BL/6J mice were used to establish a full-thickness skin defect model and randomly divided into six groups (<i>n</i> = 5 per group): Control group, Model group, Gln treatment group (Gln), Gln combined with MEK inhibitor U0126 group (Gln + MEK inhibitor), Gln combined with GLS1 inhibitor group (Gln+GLS1 inhibitor), and Gln combined with SLC1A5 inhibitor group (Gln+SLC1A5 inhibitor). Immunofluorescence (IF) was used to detect the angiogenesis marker CD31, the fibroblast activation marker α-smooth muscle actin (α-SMA), and macrophage polarization markers (CD86 for M1, CD206 for M2). Gln upregulates the expression of SLC1A5 by activating MEK/ERK pathway, thus promoting Gln metabolic reprogramming and accelerating acute wound healing. This subsequently drives M2 macrophage polarization, angiogenesis, and tissue remodeling. Our findings elucidate the critical role of the Gln metabolism-immune regulation axis in wound repair and provide a novel therapeutic target for metabolically targeted wound interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Glutamine promotes acute wound healing by mediating glutamine metabolism and M2 macrophage polarization via the MEK/ERK/SLC1A5 signaling pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月19日

查看全文
  • Yan Shi,
  • Mingheng Pan,
  • Xue Chen,
  • Ye Bi,
  • Xiaolong Wei,
  • Feiyang Zheng,
  • Hao Xia,
  • Xiaoqing He

摘要

To demonstrate glutamine (Gln) promotes acute wound healing by mediating Gln metabolism and macrophage M2 polarization through the Mitogen-Activated Protein Kinase Kinase (MEK)/Extracellular Regulated Protein Kinases (ERK)/Solute Carrier Family 1 Member 5 (SLC1A5) signaling axis.Thirty C57BL/6J mice were used to establish a full-thickness skin defect model and randomly divided into six groups (n = 5 per group): Control group, Model group, Gln treatment group (Gln), Gln combined with MEK inhibitor U0126 group (Gln + MEK inhibitor), Gln combined with GLS1 inhibitor group (Gln+GLS1 inhibitor), and Gln combined with SLC1A5 inhibitor group (Gln+SLC1A5 inhibitor). Immunofluorescence (IF) was used to detect the angiogenesis marker CD31, the fibroblast activation marker α-smooth muscle actin (α-SMA), and macrophage polarization markers (CD86 for M1, CD206 for M2). Gln upregulates the expression of SLC1A5 by activating MEK/ERK pathway, thus promoting Gln metabolic reprogramming and accelerating acute wound healing. This subsequently drives M2 macrophage polarization, angiogenesis, and tissue remodeling. Our findings elucidate the critical role of the Gln metabolism-immune regulation axis in wound repair and provide a novel therapeutic target for metabolically targeted wound interventions.